News and Updates

AstraZeneca shares dropped 9% after a key heart drug trial failed. Read our analysis on the clinical impact and what this means for the company's future.

New trial data shows SAT-3247 reduces muscle fat infiltration in adults with Duchenne muscular dystrophy, offering a potential breakthrough in muscle repair.

New phase 3 data shows setmelanotide effectively treats hypothalamic obesity by targeting MC4R signaling. Discover the potential breakthrough in weight loss.

Can a vaccine stop opioid overdoses? Explore the latest science behind fentanyl immunization and the complex clinical challenges facing researchers today.

A new study explores the performance of Nanox's AI solution in cardiac imaging, aiming to enhance diagnostic speed and accuracy in cardiovascular care.

Explore how a unique Delhi puppet show is blending traditional performance art with the complexities of DNA and genetics to spark new scientific interest.

A breakthrough clinical trial offers new hope for babies with fetal kidney failure, potentially transforming the prognosis for congenital renal conditions.

Insilico Medicine’s AI-discovered drug, Rentosertib, enters Phase III trials for IPF. A breakthrough in AI-driven drug development for lung fibrosis.

Seegene launches a landmark one-million-patient global study to set new international standards for molecular diagnostic testing and syndromic accuracy.

HHS launches a new national pledge to improve hospital food quality, prioritizing patient nutrition to support recovery and reduce chronic disease outcomes.